Multinational computer tech company Oracle today announced the launch of its Oracle Health Sciences mHealth connector cloud service designed to aid clinical study teams in remotely collecting data from patient sensors, wearable and apps for use in clinical trials. The newly launched system is designed to improve the ease of collecting data from a number […]
It’s time for implantable heart pump maker Thoratec Corp. (NSDQ:THOR) to throw in the towel and sell itself off, according to Oracle Investment Management.
Thoratec needs a more seasoned company to help it push past a period of sluggish growth, meaning that putting the cardiac assist device firm up for auction is best for shareholders, according to the activist investor group.
Phase Forward Inc. (NSDQ:PFWD) is another step closer to merging with software giant Oracle Corp. (NSDQ:ORCL).
The U.S. Dept. of Justice gave the companies clearance to proceed with their $685 million deal, announced in April.
Shareholders of Phase Forward Inc. (NSDQ:PFWD) voted to approve a $685 million acquisition bid from Oracle Corp. (NSDQ:ORCL).
The Waltham, Mass.-based clinical trial data management firm also announced the dismissal of a lawsuit filed by stockholders, accusing the company and its management of breaching their fiduciary duties in agreeing to the merger and seeking to block the deal.
The U.S. Dept. of Justice is investigating Oracle Corp.’s (NSDQ:ORCL) $685 million bid to acquire Phase Forward Inc. (NSDQ: PFWD), according to a filing with the Securities and Exchange Commission.
The Waltham, Mass.-based clinical trial data management provider said it received a “Request for Additional Information” May 27 from the Justice Dept., meaning an extension of the waiting period imposed by the Hart-Scott-Rodino Antitrust Improvements Act of 1976, according to the filing.
Oracle Corp. (NSDQ:ORCL) agreed to pay $17 per share in cash, or about $685 million, to acquire Phase Forward Inc. (NSDQ: PFWD).
The deal, expected to close in mid-2010, will see the Waltham, Mass.-based clinical trial data management provider integrated into the global health sciences division Oracle established in June 2008.